Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 32 out of 100. Down syndrome and Alzheimer's

Topic: Brain proteins, microglia and lab models

Studies of Alzheimer amyloid protein precursor mRNA expression in the human brain have provided compelling evidence for a neural origin of beta amyloid. Significant alterations in levels of amyloid precursor mRNAs are observed specifically in neurons known to be risk in Alzheimer's disease and Down syndrome. These data raise the possibility that an increase in the transcripts containing the protease inhibitor domain relative to the shorter transcript may account for the accumulation of beta amyloid.

Key findings

Why it matters

This early work found altered levels of amyloid precursor mRNA specifically in neurons at risk in Alzheimer's disease and Down syndrome, suggesting a neuronal source of beta amyloid. It raises the possibility that a shift toward the transcript containing the protease inhibitor domain may explain beta amyloid accumulation, but no treatment or prevention is tested here.

Study details

How this study scored 32/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 4 of 4; Institution's track record 1 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 32 of 100.32 of 100 points earned68 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Neurobiology of aging)
Journal's citation record 3 / 4 Neurobiology of Aging: journal h-index 263 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 1989 — older than 20 years, still counted
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 5 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.1 citations a year over 39 year(s) since 1989
Impact for its field and year 1 / 6 Cited 0.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author Rachael L. Neve: h-index 124 (OpenAlex, whole career)
Institution's track record 1 / 3 Boston Children's Hospital: institution h-index 1,088 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 2510036)
Free to read 0 / 2 Behind a paywall — scores zero
Total 32 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Neve, R. L. (1989). Genetic studies support a neuronal origin for the beta amyloid polypeptide. Neurobiology of aging. https://doi.org/10.1016/0197-4580(89)90074-2

Vancouver

Neve RL. Genetic studies support a neuronal origin for the beta amyloid polypeptide. Neurobiology of aging. 1989. doi:10.1016/0197-4580(89)90074-2. PMID: 2510036.

BibTeX

@article{neve1989-2510036,
  author  = {Neve, R. L.},
  title   = {{Genetic studies support a neuronal origin for the beta amyloid polypeptide}},
  journal = {Neurobiology of aging},
  year    = {1989},
  doi     = {10.1016/0197-4580(89)90074-2},
  pmid    = {2510036},
  url     = {https://doi.org/10.1016/0197-4580(89)90074-2}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Down syndrome and Alzheimer's

Similar studies

More on Down syndrome and Alzheimer's

See all studies in Down syndrome and Alzheimer's →